Rate My Professor Eva Dimitriadis

Associate Professor Eva Dimitriadis is an NHMRC Senior Research Fellow and Adjunct Associate Professor in the Department of Anatomy and Developmental Biology at Monash University. She serves as Research Group Head of the Embryo Implantation Laboratory in the Centre for Reproductive Health at the Hudson Institute of Medical Research. Additionally, she holds the position of Professor in Reproductive Biology and Co-Director of the Gynaecology Research Centre at the University of Melbourne. After obtaining her Bachelor of Science degree in Melbourne, she accumulated eight years of experience as a research assistant in Melbourne, Munich, and Dublin. She then completed her PhD at Trinity College Dublin, Ireland, followed by postdoctoral studies at the University of Dublin, before returning to Australia to initiate her independent research career at Prince Henry's Institute, now the Hudson Institute of Medical Research. She also lectures in the Education Program in Reproductive Biology at Monash University.

Professor Dimitriadis's research specializes in reproductive biology, with a focus on infertility, endometrial receptivity to implanting embryos, endometrial-trophoblast interactions during implantation, and the development of non-invasive biomarkers of implantation potential. Her investigations include microRNA regulation of these processes, novel sustained-release targeted delivery systems, new non-hormonal contraceptives that prevent sexually transmitted diseases, and treatments for endometrial cancer. She has authored numerous high-impact publications, including 'Interleukin-11 alters placentation and causes preeclampsia features in mice' in PNAS (2015), 'Transcytosis of IL-11 and Apical Redirection of gp130 Is Mediated by IL-11α Receptor' in Cell Reports (2016), 'Fertile ground: human endometrial programming and lessons in health and disease' in Nature Reviews Endocrinology (2016), and 'Targeting Interleukin-11 receptor-α impairs human endometrial cancer cell proliferation and invasion in vitro and reduces tumour growth and metastasis in vivo' in Molecular Cancer Therapeutics (2016). Her work features translational applications in pre-clinical trials and fosters collaborations with institutions such as Monash IVF, the Walter and Eliza Hall Institute, University of Melbourne, University of Tokyo, Commonwealth Serum Laboratories, and the Karolinska Institutet, contributing to SDG 3 (Good Health and Well-being) and SDG 5 (Gender Equality).